TH and Parkinson disease: As such, cyclic nucleotide-mediated signaling offers a dual approach in Parkinson's disease treatment, replenishing dopamine levels through tyrosine hydroxylase Ser40 phosphorylation to alleviate motor symptoms and concurrently promoting neuroprotection.